Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Phase 3 Completed
203 enrolled 22 charts
NICE
Phase 2/3 Completed
104 enrolled
CHARIOT
Phase 1 Completed
36 enrolled 24 charts
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Phase 2 Completed
55 enrolled
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Phase 1/2 Completed
73 enrolled 18 charts
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Phase 2 Completed
97 enrolled 9 charts
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Phase 2 Completed
25 enrolled
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Phase 2 Completed
257 enrolled 13 charts
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Phase 3 Completed
344 enrolled 11 charts
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
Phase 2 Completed
62 enrolled 8 charts
Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
Phase 1/2 Completed
59 enrolled 8 charts
Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery
Completed
6 enrolled
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION
Completed
11 enrolled
Chemoradiation and Panitumumab for Esophageal Cancer
Phase 2 Completed
78 enrolled
Trimodality Management of T1b Esophageal Cancers
Phase 1/2 Completed
4 enrolled 8 charts
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer
Phase 2 Completed
110 enrolled
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Phase 1 Completed
61 enrolled
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Phase 3 Completed
546 enrolled 11 charts
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
Phase 3 Completed
195 enrolled
Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer
Phase 2 Completed
74 enrolled 24 charts
PALAESTRA
Phase 2 Completed
29 enrolled
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
Phase 1 Completed
3 enrolled
ROCS
Phase 3 Completed
220 enrolled
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 1 Completed
9 enrolled
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Phase 2 Completed
82 enrolled 9 charts
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
73 enrolled 13 charts
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Phase 2 Completed
35 enrolled
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
Phase 3 Completed
220 enrolled
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
43 enrolled 5 charts
Positron Emission Tomography in Determining Stage of Esophageal Cancer
Phase NA Completed
235 enrolled
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
56 enrolled
Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Completed
56 enrolled
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Phase 2 Completed
34 enrolled 5 charts
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas
Phase 2 Completed
41 enrolled 18 charts
Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
Phase 1 Completed
10 enrolled
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
22 enrolled 13 charts
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
Phase 2 Completed
70 enrolled 15 charts
CCRT for Esophageal Cancer.
Phase 2 Completed
34 enrolled
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
Phase 2/3 Completed
266 enrolled
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
Phase 2 Completed
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
Phase 2 Completed
80 enrolled
POXX
Phase 1/2 Completed
29 enrolled 10 charts
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
Phase 2 Completed
126 enrolled 8 charts
Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction
Phase 1/2 Completed
25 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Phase 2 Completed
21 enrolled
Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
Phase 3 Completed
40 enrolled
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
Phase 2 Completed
41 enrolled 8 charts
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
Phase 2 Completed
98 enrolled 9 charts
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
Phase 2 Completed
53 enrolled
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
Phase NA Completed
700 enrolled